3 weeks Biotech Stock Roundup: REGN Up on Q4 Results, VRTX, AXSM Gain on Drug Approval Zacks

REGN and AMGN are in the spotlight this week on fourth-quarter earnings release.

Amgen (AMGN) · Biotech · Earnings · Regeneron Pharma (REGN) · Vertex (VRTX)